Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Base de datos
Tipo de estudio
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Clin Endosc ; 57(1): 58-64, 2024 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-37157958

RESUMEN

BACKGROUND/AIMS: Radiofrequency treatment of the gastroesophageal junction using the Stretta procedure for treating gastroesophageal reflux disease (GERD) is observed to improve the symptoms and proton pump inhibitor (PPI) dependence and reduce the need for anti-reflux operations. As one of the largest studies in Europe, we evaluated the clinical outcomes of Stretta in patients with medically refractory GERD. METHODS: A tertiary UK center evaluated all patients with refractory GERD who underwent Stretta between 2014 and 2022. Patients and primary care professionals were contacted to obtain information regarding the initiation of PPI and reintervention after Stretta. RESULTS: Of the 195 patients (median age, 55 years; 116 women [59.5%]) who underwent Stretta, PPI-free period (PFP) data were available for 144 (73.8%) patients. Overall, 66 patients (45.8%) did not receive PPI after a median follow-up of 55 months. Six patients (3.1%) underwent further interventions. The median PFP after Stretta was 41 months. There was a significant negative correlation between PFP and age (p=0.007), with no differences between sexes (p=0.96). Patients younger than 55 years of age had a longer PFP than their older counterparts (p=0.005). Younger males had a significantly longer PFP than older males (p=0.021). However, this was not observed in the female cohort (p=0.09) or between the younger men and women (p=0.66). CONCLUSION: Our findings suggest that Stretta is a safe and feasible option for treating refractory GERD, especially in younger patients. It prevents further anti-reflux interventions in most patients and increases the lead-time to surgery in patients with refractory GERD.

2.
Cureus ; 13(10): e18900, 2021 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-34820221

RESUMEN

Bilateral facial nerve palsy is a rare condition, representing only 0.3-2.0% of all facial palsy cases. Facial paralysis constitutes the result of a diverse array of systemic disorders and heterogeneous aetiologies and thus represents a diagnostic challenge. This case report describes a previously healthy male who presented to the emergency department numerous times within a few weeks with unrelated non-specific symptoms. These symptoms could not be attributed to any specific aetiology after various radiological and laboratory examinations, and hence presented a diagnostic dilemma until he developed bilateral seventh nerve palsy and was admitted for a further workup.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA